Bruker Corp (NASDAQ: BRKR) started the day on Thursday, with a price increase of 2.85% at $38.97, before settling in for the price of $37.89 at the close. Taking a more long-term approach, BRKR posted a 52-week range of $34.10-$83.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 10.58% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -9.69%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.58%. This publicly-traded company’s shares outstanding now amounts to $151.68 million, simultaneously with a float of $102.90 million. The organization now has a market capitalization sitting at $5.90 billion. At the time of writing, stock’s 50-day Moving Average stood at $44.24, while the 200-day Moving Average is $56.90.
Bruker Corp (BRKR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Bruker Corp’s current insider ownership accounts for 32.09%, in contrast to 81.30% institutional ownership. According to the most recent insider trade that took place on Mar 10 ’25, this organization’s Chief Accounting Officer bought 500 shares at the rate of 47.40, making the entire transaction reach 23,698 in total value, affecting insider ownership by 3,472. Preceding that transaction, on Feb 18 ’25, Company’s PRESIDENT & CEO bought 20,000 for 50.92, making the whole transaction’s value amount to 1,018,330. This particular insider is now the holder of 38,459,563 in total.
Bruker Corp (BRKR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.57 per share during the current fiscal year.
Bruker Corp’s EPS increase for this current 12-month fiscal period is 7.58% and is forecasted to reach 2.98 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.38% through the next 5 years, which can be compared against the -9.69% growth it accomplished over the previous five years trading on the market.
Bruker Corp (NASDAQ: BRKR) Trading Performance Indicators
Let’s observe the current performance indicators for Bruker Corp (BRKR). It’s Quick Ratio in the last reported quarter now stands at 0.77. The Stock has managed to achieve an average true range (ATR) of 2.36. Alongside those numbers, its PE Ratio stands at $51.32, and its Beta score is 1.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.75. Similarly, its price to free cash flow for trailing twelve months is now 43.42.
In the same vein, BRKR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.76, a figure that is expected to reach 0.44 in the next quarter, and analysts are predicting that it will be 2.98 at the market close of one year from today.
Technical Analysis of Bruker Corp (BRKR)
If we take a close look at the recent performances of Bruker Corp (NASDAQ: BRKR), its last 5-days Average volume was 2.38 million that shows progress from its year to date volume of 2.05 million. During the previous 9 days, stock’s Stochastic %D was recorded 52.23% While, its Average True Range was 2.34.
Raw Stochastic average of Bruker Corp (BRKR) in the period of the previous 100 days is set at 15.95%, which indicates a major fall in contrast to 67.27% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 81.67% that was higher than 49.13% volatility it exhibited in the past 100-days period.
